Table 3.
Variables | Groups | Before | After | Changes | P-Value b | P- value# |
---|---|---|---|---|---|---|
Weight, kg | Propolis | 79.05 ± 8.61 | 77.97 ± 8.52 | −1.08 ± 2.43 | 0.016 | |
Placebo | 82.02 ± 13.42 | 81.64 ± 13.08 | −0.38 ± 1.98 | 0.310 | 0.550* | |
P-Value | 0.298 | |||||
BMI, kg/m2 | Propolis | 32.57 ± 4.13 | 32.12 ± 4.06 | −0.45 ± 1 | 0.016 | |
Placebo | 34.03 ± 4.79 | 33.88 ± 4.73 | −0.15 ± 0.84 | 0.348 | 0.217 | |
P-Value | 0.201 | |||||
Waist circumference, cm | Propolis | 107.17 ± 7.89 | 104.08 ± 6.96 | −3.09 ± 4 | < 0.001 | |
Placebo | 109.83 ± 9.99 | 109.66 ± 10.26 | −0.17 ± 4.36 | 0.833 | 0.008 | |
P-Value | 0.246 | |||||
SBP, mmHg | Propolis | 12.83 ± 1.67 | 12.16 ± 1.23 | −0.67 ± 1.58 | 0.020 | |
Placebo | 13.02 ± 1.63 | 12.67 ± 1.37 | −0.34 ± 1.21 | 0.137 | 0.366 | |
P-Value | 0.663 | |||||
DBP, mmHg | Propolis | 8.38 ± 1.07 | 8.08 ± 0.91 | −0.30 ± 1.41 | 0.237 | |
Placebo | 8.55 ± 1.21 | 8.26 ± 0.85 | −0.29 ± 1.31 | 0.237 | 0.995 | |
P-Value | 0.551 | 0.438 | ||||
LDL/HDL ratio | Propolis | 2.06 ± 0.47 | 2.06 ± 0.32 | −0.01 ± 0.42 | 0.934 | |
Placebo | 2 ± 0.57 | 2.11 ± 0.39 | 0.11 ± 0.48 | 0.211 | 0.296 | |
P-Value | 0.631 | |||||
Cholesterol/HDL ratio | Propolis | 3.66 ± 0.45 | 3.70 ± 0.44 | 0.05 ± 0.41 | 0.525 | |
Placebo | 3.60 ± 0.55 | 3.72 ± 0.44 | 0.12 ± 0.55 | 0.257 | 0.760 | |
P-Value | 0.673 | |||||
TG, mg/dl | Propolis | 239.97 ± 169.76 | 234.33 ± 144.94 | −5.64 ± 212.18 | 0.880 | |
Placebo | 224.34 ± 129.58 | 288.34 ± 192 | 64 ± 225.16 | 0.137 | 0.215 | |
P-Value | 0.688 | |||||
Insulin, μU/ml | Propolis | 4.87 [3.73–8.81] | 7.34 [3.88–8.88] | 0.75 ± 3.69 | 0.357a | |
Placebo | 5.38 [3.2–8.89] | 6.37 [4.12–9.47] | 0.64 ± 2.51 | 0.163a | 0.890 | |
P-Value | 0.849 | |||||
FBG, mg/dl | Propolis | 126 [112.5–168.5] | 123 [104–172] | −5.06 ± 57.11 | 0.381a | |
Placebo | 123 [108–174.5] | 133 [114–160] | 0.48 ± 53.53 | 0.387a | 0.197* | |
P-Value | 0.827 | |||||
HOMO-IR | Propolis | 1.93 [1.22–2.88] | 1.90 [1.29–3.05] | 0.42 ± 2.33 | 0.662a | |
Placebo | 1.57 [1.04–2.96] | 1.84 [1.26–3.43] | 0.33 ± 1.28 | 0.107a | 0.805* | |
P-Value | 0.530 | |||||
TC, mg/dl | Propolis | 168 [143.5–198] | 141 [129–187] | −9.42 ± 34.98 | 0.039a | |
Placebo | 180 [150.5–199.5] | 162 [140–201.5] | −10.55 ± 31.41 | 0.106a | 0.895 | |
P-Value | 0.489 | |||||
HDL-C, mg/dl | Propolis | 45 [39.5–57] | 41 32,36–50 | −2.52 ± 14.42 | 0.022a | |
Placebo | 50 [42.5–54.5] | 44 [37.5–51.5] | −4.14 ± 8.65 | 0.003a | 0.865* | |
P-Value | 0.259 | |||||
LDL-C, mg/dl | Propolis | 93 [77.5–109.5] | 79 [69.5–109] | −3.70 ± 37.73 | 0.114a | 0.682* |
Placeo | 94 [76–124.5] | 90 [78–123] | −2.52 ± 29.03 | 0.406a | ||
P-Value | 0.899 | |||||
CRP, mg/l | Propolis | 1.4 [0.2–2.65] | 1.8 [0.25–4.3] | 0.56 ± 3.59 | 0.084a | |
Placebo | 1.8 [0.2–5.15] | 2.8 [1–5.1] | −0.48 ± 7.23 | 0.838a | 0.341* | |
P-Value | 0.329 |
Values are presented as mean ± standard deviation and median [interquartile range]. Abbreviation: FBS, fasting blood sugar; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, homeostasis model of assessment-insulin resistance; CRP, C- reactive protein; TC, total cholesterol; SBD, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index. * P-value were derived from Mann-Whiney U test. # P-value were derived from Independent t test. b P-value were derived from paired-sample t test. a P-value were obtained from Wilcoxon rank-sum test.